Horizon Discovery Raises $18.6M in Series C Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has raised £11.3 million ($18.6 million) in a Series C round of financing.

The Cambridge, UK-based maker of research tools for personalized medicine and drug discovery said that the funds will be used to improve its core technology platforms, strengthen its intellectual property position, and expand into new disease areas outside of its historical focus on cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."